Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study

AbstractPurpose This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications.M...

Full description

Bibliographic Details
Main Authors: Yanting Hu, Guoliang Xue, Xinyu Liang, Zhichao Li, Nan Wang, Pikun Cao, Gang Wang, Haitao Zhang, Xiaohuan Zheng, Aiguang Wang, Wenhua Zhao, Cuiping Han, Zhigang Wei, Xin Ye
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2024.2307479
_version_ 1797324144314941440
author Yanting Hu
Guoliang Xue
Xinyu Liang
Zhichao Li
Nan Wang
Pikun Cao
Gang Wang
Haitao Zhang
Xiaohuan Zheng
Aiguang Wang
Wenhua Zhao
Cuiping Han
Zhigang Wei
Xin Ye
author_facet Yanting Hu
Guoliang Xue
Xinyu Liang
Zhichao Li
Nan Wang
Pikun Cao
Gang Wang
Haitao Zhang
Xiaohuan Zheng
Aiguang Wang
Wenhua Zhao
Cuiping Han
Zhigang Wei
Xin Ye
author_sort Yanting Hu
collection DOAJ
description AbstractPurpose This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications.Methods Between May 2020 and April 2022, 71 patients with 71 RML pulmonary nodules underwent 71 MWA sessions. To comparison, 142 patients with 142 pulmonary nodules in non-RML were selected using propensity score matching. The technical success, technique efficacy, complications, and associated factors were analyzed. The duration of the procedure and post-ablation hospital stay were also recorded.Results Technical success was achieved in 100% of all patients. There were no significant differences in technique efficacy rates between the RML and non-RML groups (97.2% vs. 95.1%, p = 0.721). However, both major (47.9% vs. 19.7%, p < 0.001) and minor (26.8% vs. 11.3%, p = 0.004) pneumothorax were more common in the RML group than non-RML group. MWA for RML pulmonary nodules was identified as an independent risk factor for pneumothorax (p < 0.001). The duration of procedures (51.7 min vs. 35.3 min, p < 0.001) and post-ablation hospital stays (4.7 days vs. 2.8 days, p < 0.001) were longer in the RML group than non-RML group.Conclusions CT-guided MWA for RML pulmonary nodules showed comparable efficacy compared with other lobes, but posed a higher risk of pneumothorax complications, necessitating longer MWA procedure times and extended hospital stays.
first_indexed 2024-03-08T05:45:57Z
format Article
id doaj.art-a64b001bd89a41e9a753d55261defbd8
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-03-08T05:45:57Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-a64b001bd89a41e9a753d55261defbd82024-02-05T10:41:22ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2024.2307479Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control studyYanting Hu0Guoliang Xue1Xinyu Liang2Zhichao Li3Nan Wang4Pikun Cao5Gang Wang6Haitao Zhang7Xiaohuan Zheng8Aiguang Wang9Wenhua Zhao10Cuiping Han11Zhigang Wei12Xin Ye13Department of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaDepartment of Oncology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Jinan, ChinaAbstractPurpose This retrospective, single-center, case-control study evaluated the safety and efficacy of Computed tomography (CT)-guided microwave ablation (MWA) for pulmonary nodules located in the right middle lobe (RML), a challenging location associated with a high frequency of complications.Methods Between May 2020 and April 2022, 71 patients with 71 RML pulmonary nodules underwent 71 MWA sessions. To comparison, 142 patients with 142 pulmonary nodules in non-RML were selected using propensity score matching. The technical success, technique efficacy, complications, and associated factors were analyzed. The duration of the procedure and post-ablation hospital stay were also recorded.Results Technical success was achieved in 100% of all patients. There were no significant differences in technique efficacy rates between the RML and non-RML groups (97.2% vs. 95.1%, p = 0.721). However, both major (47.9% vs. 19.7%, p < 0.001) and minor (26.8% vs. 11.3%, p = 0.004) pneumothorax were more common in the RML group than non-RML group. MWA for RML pulmonary nodules was identified as an independent risk factor for pneumothorax (p < 0.001). The duration of procedures (51.7 min vs. 35.3 min, p < 0.001) and post-ablation hospital stays (4.7 days vs. 2.8 days, p < 0.001) were longer in the RML group than non-RML group.Conclusions CT-guided MWA for RML pulmonary nodules showed comparable efficacy compared with other lobes, but posed a higher risk of pneumothorax complications, necessitating longer MWA procedure times and extended hospital stays.https://www.tandfonline.com/doi/10.1080/02656736.2024.2307479Right middle lobepulmonary nodulemicrowave ablationcomplicationpneumothorax
spellingShingle Yanting Hu
Guoliang Xue
Xinyu Liang
Zhichao Li
Nan Wang
Pikun Cao
Gang Wang
Haitao Zhang
Xiaohuan Zheng
Aiguang Wang
Wenhua Zhao
Cuiping Han
Zhigang Wei
Xin Ye
Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
International Journal of Hyperthermia
Right middle lobe
pulmonary nodule
microwave ablation
complication
pneumothorax
title Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
title_full Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
title_fullStr Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
title_full_unstemmed Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
title_short Computed tomography-guided microwave ablation for right middle lobe pulmonary nodules: a retrospective, single-center, case-control study
title_sort computed tomography guided microwave ablation for right middle lobe pulmonary nodules a retrospective single center case control study
topic Right middle lobe
pulmonary nodule
microwave ablation
complication
pneumothorax
url https://www.tandfonline.com/doi/10.1080/02656736.2024.2307479
work_keys_str_mv AT yantinghu computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT guoliangxue computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT xinyuliang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT zhichaoli computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT nanwang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT pikuncao computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT gangwang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT haitaozhang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT xiaohuanzheng computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT aiguangwang computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT wenhuazhao computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT cuipinghan computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT zhigangwei computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy
AT xinye computedtomographyguidedmicrowaveablationforrightmiddlelobepulmonarynodulesaretrospectivesinglecentercasecontrolstudy